CNBC has launched CNBC Cures, a new initiative led by anchor Becky Quick, to amplify awareness and support for the 30 million Americans living with rare diseases. The effort stems from Quick’s personal experience with her family’s rare disease journey.
- CNBC Cures launched on January 8, 2026, targeting 30 million Americans affected by rare diseases.
- Led by CNBC anchor Becky Quick, the initiative stems from her family’s experience with a rare disease.
- 95% of rare diseases currently lack FDA-approved treatments, according to national health data.
- Average diagnostic delay for rare diseases exceeds seven years, a key focus area for the initiative.
- CNBC Cures will collaborate with patient advocacy organizations and medical institutions.
- The program emphasizes education, early diagnosis, treatment access, and policy awareness.
CNBC Cures, a new public awareness initiative from CNBC, officially launched on January 8, 2026, with the goal of informing and connecting the 30 million Americans affected by rare diseases. The initiative is spearheaded by Becky Quick, anchor of CNBC’s flagship morning program, "Squawk Box," who drew from her family’s firsthand experience navigating a rare disease diagnosis to drive the project’s mission. The program will feature in-depth reporting, expert interviews, and personal stories across CNBC’s digital platforms, television broadcasts, and social media channels. By spotlighting underrepresented health issues and advancing patient advocacy, CNBC Cures aims to improve early diagnosis rates, expand access to treatment options, and encourage greater investment in rare disease research. Data shows that nearly 95% of rare diseases lack FDA-approved treatments, and the average diagnostic journey spans over seven years. CNBC Cures will focus on reducing these delays by highlighting symptoms, diagnostic tools, and emerging therapies. The initiative also plans to partner with patient advocacy groups and medical institutions to produce educational content and host community forums. The launch coincides with increased legislative attention on rare disease funding, including the Rare Diseases Act of 2025, which expanded federal support for research and data sharing. CNBC Cures positions itself as a media platform to empower patients, caregivers, and healthcare professionals with actionable information and a stronger voice in the national health conversation.